¹ The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Myeloma Research, Department of Medical Oncology, Dana-Farber Cancer Institute, and ² Veterans Administration Boston Healthcare System, Harvard Medical School, Boston, MA; and ³ Nereus Pharmaceuticals, San Diego, CA

Bortezomib, Doxorubicin and Dexamethasone in Advanced Multiple Myeloma-

http://www.medscape.com/v...

 The reason I posted this study is first that this is another possible drug combination for those mmers who are refractory and second, that the study cites the synergies of bortazimb when combined with other chemos-